Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial-Reference-Cited by-同舟云学术

Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial

Published:2013-08 Issue:6 Volume:1 Page:471-478
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Peter Jonathan G,Theron Grant,Pooran Anil,Thomas Johnson,Pascoe Mellissa,Dheda Keertan

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference34 articles.

1. WHO Report 2011: global tuberculosis control,2011

2. Tuberculosis control and elimination 2010–50: cure, care, and social development;Lonnroth;Lancet,2010

3. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes;Getahun;Lancet,2007

4. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system,2011

5. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study;Boehme;Lancet,2011

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Operational indicators for pulmonary tuberculosis diagnosis in people living with HIV before and after Xpert MTB/RIF implementation in the state of São Paulo, Brazil;PLOS ONE;2024-06-07

2. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study;The Lancet Global Health;2024-05

3. Tuberculosis in prisons: a growing global health concern;The Challenge of Tuberculosis in the 21st Century;2023-09-01

4. Do private providers initiate anti-tuberculosis therapy on the basis of chest radiographs? A standardised patient study in urban India;The Lancet Regional Health - Southeast Asia;2023-06

5. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study;2023-06-01